for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sinovac Biotech Ltd.

SVA.O

Latest Trade

6.47USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

6.25

 - 

6.58

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
6.47
Open
--
Volume
--
3M AVG Volume
0.00
Today's High
--
Today's Low
--
52 Week High
6.58
52 Week Low
6.25
Shares Out (MIL)
71.52
Market Cap (MIL)
639.90
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

EMA Starts Rolling Review Of COVID-19 Vaccine (Vero Cell) Inactivated

Sinovac Reports Q4 EPS $0.96

Pharmaniaga Says Unit Signed Deal With Sinovac For Ready-To-Fill Bulk Product Of COVID-19 Vaccine

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Sinovac Biotech Ltd.

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Industry

Biotechnology & Drugs

Contact Info

39 Shangdi Xi Road, Haidian District

BEIJING, BEJ

102200

China

+86.10.56931800

http://www.sinovac.com/

Executive Leadership

WeiDong Yin

Chairman of the Board, President, Chief Executive Officer, Secretary

Nan Wang

Chief Financial Officer, Vice President

Xiaomei Yin

Vice President - Sales and Marketing

Qiang Gao

Vice President - Research and Development

Jing Li

Vice President - Quality and Production

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
2.42
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
14.79
Total Debt To Equity (MRQ)
19.49
LT Debt To Equity (MRQ)
7.55
Return on Investment (TTM)
13.27
Return on Equity (TTM)
8.47

Latest News

Latest News

Brazil to halt Sinovac vaccine production as Chinese supplies held up

Brazil will run out of raw materials to produce Sinovac Biotech Ltd's COVID-19 vaccine by Friday, as a supply shipment has been held up in Chinese export clearance, authorities in the state of Sao Paulo said on Wednesday.

EU regulator begins real-time review of first Chinese COVID-19 vaccine

Europe's medicines regulator said on Tuesday it has started a real-time review of Sinovac's COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus.

EU drug regulator begins real-time review of Sinovac's COVID-19 vaccine

Europe's medicines regulator said on Tuesday it has started a real-time review of Sinovac's COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus.

UPDATE 1-Thailand to receive 3.5 mln more doses of Sinovac vaccine in May

Thailand will next month receive another 3.5 million doses of Sinovac Biotech's coronavirus vaccine, a senior health official said on Friday, as the country seeks to shore-up supplies amid its biggest outbreak so far.

Brazil Senate votes to suspend patent protection on COVID-19 vaccines

Brazil's Senate on Thursday approved a bill to suspend patent protection for COVID-19 vaccines, tests and medications during the pandemic, sending the proposal to the lower house of Congress for consideration and possible amendments.

Egypt approves China's Sinovac coronavirus vaccine for emergency use

Egypt's drug authority said on Monday it had granted approval to China's Sinovac coronavirus vaccine for emergency use.

WHO sets dates for reviews of Sinopharm and Sinovac COVID-19 vaccines

Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm's COVID-19 vaccine for possible emergency use listing, to be followed by the Sinovac jab on May 3, the agency said on Thursday.

ANALYSIS-Chile's COVID-19 vaccine drive shifts to second doses over protection, supply concerns

Chile is shifting its COVID-19 vaccination strategy toward issuing second doses, while slowing administration of new shots, due to concerns over supply shortages and data showing scant protection from one dose of the Sinovac Biotech vaccine that formed the backbone of its...

Guinea receives purchase of 300,000 Sinovac COVID-19 vaccines

Guinea received on Sunday a shipment of 300,000 Sinovac COVID-19 vaccines purchased from China and is also set to receive a donation of 200,000 Sinopharm shots, Guinean Foreign Minister Ibrahima Khalil Kaba said.

Egypt to produce up to 80 million Sinovac vaccine doses annually - minister

Egypt has agreed with China's Sinovac Biotech Ltd to manufacture its COVID-19 vaccine domestically, and could produce up to 80 million doses a year, the health ministry said on Thursday.

Egypt to produce up to 60 mln Sinovac vaccine doses annually- minister

Egypt has agreed with China's Sinovac Biotech Ltd to manufacture its COVID-19 vaccine domestically, aiming to produce up to 60 million doses per year, its health minister Hala Zayed said on Thursday.

Philippines allows use of Sinovac's COVID-19 vaccine for senior citizens

Philippine health authorities on Wednesday allowed the use of Sinovac's COVID-19 vaccine for some senior citizens after initially limiting coverage to people aged 18-59 years, as the country battles one of Asia's worst coronavirus outbreaks.

China to donate 150,000 Sinovac COVID-19 vaccine doses to El Salvador

El Salvador's President Nayib Bukele said on Sunday that China will donate 150,000 Sinovac COVID-19 vaccine doses to the Central American nation, on top of the 2 million Sinovac jabs his government already purchased.

Ukraine approves Chinese vaccine as COVID-19 cases hit new record high

Ukraine has approved China's Sinovac vaccine to fight the coronavirus pandemic, the health ministry said on Saturday, after the country recorded a record rise in new COVID-19 cases for the second day in a row.

China Sinovac says it reached two billion doses annual capacity for COVID-19 vaccine

China's Sinovac Biotech said on Friday its third production plant for its COVID-19 vaccine was ready and had started manufacturing procedures for bulk vaccine ingredient, doubling its annual capacity to 2 billion doses.

Sinopharm, Sinovac COVID-19 vaccine data show efficacy: WHO

Chinese vaccine makers Sinopharm and Sinovac have presented data on their COVID-19 vaccines indicating levels of efficacy that would be compatible with those required by the World Health Organization, the chair of a WHO advisory panel said on Wednesday.

Sinopharm, Sinovac COVID-19 vaccine data show efficacy - WHO

Chinese vaccine makers Sinopharm and Sinovac have presented data on their COVID-19 vaccines indicating levels of efficacy that would be compatible with those required by the World Health Organization, the chair of a WHO advisory panel said on Wednesday.

Sinopharm needs trial results to decide if COVID-19 vaccine needs booster shot: executive

China National Pharmaceutical Group (Sinopharm) will need to assess results from overseas Phase III clinical trials to decide whether its two-shot COVID-19 vaccine should be followed by a booster shot, a company executive said on Sunday.

Erdogan says he reminded Chinese minister that Turkey expects 50 mln doses of COVID-19 vaccines

President Tayyip Erdogan said on Friday he had reminded China's foreign minister during talks in Ankara on Thursday that Turkey expects to receive 50 million doses of COVID-19 vaccines from Sinovac Biotech as per a deal between the two countries.

Thailand approves Johnson & Johnson's COVID-19 vaccine - health minister

Thailand has granted emergency use authorisation to Janssen, the single-dose coronavirus vaccine of Johnson & Johnson, the country's health minister said on Thursday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up